Sialadenitis in Antineutrophil Cytoplasmic Antibodies Vasculitis
Journal of The Association of Physicians of India · 2024
DOI: 10.59556/japi.72.0530 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of The Association of Physicians of India, 2024. Verfasst von Aditi Patankar und 3 weiteren Autor:innen. Beteiligte Einrichtung: Resident, Department of Rheumatology, P D Hinduja Hospital and Medical Research Centre, Mumbai, Maharashtra, India, Corresponding Author. Hauptthemen laut MEDLINE: Sialadenitis, Granulomatosis with Polyangiitis, Rituximab. Die Arbeit nennt 10 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Resident, Department of Rheumatology, P D Hinduja Hospital and Medical Research Centre, Mumbai, Maharashtra, India, Corresponding Author.
- Consultant Pulmonologist , Department of Pulmonary Medicine, Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute, Mumbai, Maharashtra, India.
- Consultant Rheumatologist, Department of Rheumatology, Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute, Mumbai, Maharashtra, India.
- Consultant Rheumatologist, Department of Rheumatology, P D Hinduja Hospital and Medical Research Centre, Mumbai, Maharashtra, India.
Zitieren
APA
Patankar, A., Singhania, S., Singh, S., & Balakrishnan, C. (2024). Sialadenitis in Antineutrophil Cytoplasmic Antibodies Vasculitis. Journal of The Association of Physicians of India. https://doi.org/10.59556/japi.72.0530
Vancouver
Patankar A, Singhania S, Singh S, Balakrishnan C. Sialadenitis in Antineutrophil Cytoplasmic Antibodies Vasculitis. Journal of The Association of Physicians of India. 2024. doi:10.59556/japi.72.0530
BibTeX
@article{Patankar2024,
author = {Patankar, Aditi and Singhania, Sumeet and Singh, Sunil and Balakrishnan, Canchi},
title = {Sialadenitis in Antineutrophil Cytoplasmic Antibodies Vasculitis},
journal = {Journal of The Association of Physicians of India},
year = {2024},
doi = {10.59556/japi.72.0530}
}
EUVIMED